Found 60 matching trials
Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease
PHASE4The purpose of this study is to evaluate a new questionnaire to capture the...
Location
GSK Investigational Site
New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)
EARLY_PHASE1First, the investigators will image patients with hyperpolarized xenon (Xe)...
Location
University of Virginia
Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation
N/AThis retrospective database study will assess differences in the risk of re...
Location
Multiple Locations
A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers
PHASE1Bioequivalence study between two inhaler products of fixed dose combination...
Location
BECRO Clinical Facility
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
PHASE4The purpose of this study is to assess whether the risk of serious asthma-r...
Location
GSK Investigational Site
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
PHASE4This trial is a randomized, double-blind, parallel-group, multicenter study...
Location
GSK Investigational Site
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
PHASE4The purpose of this study is to evaluate the site and mechanisms responsibl...
Location
Arthur F Gelb Medical Corporation
Comparative Study on Usability of Inhaler Devices in Adults With Asthma or COPD
NAThis is a randomized, multi-center, active-controlled, repeated measures de...
Location
3) Fondazione S. Maugeri - IRCCS - Dipartimento di Pneumologia Riabilitativa
Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations
PHASE4This study evaluates the effect of two medicines on COPD (Chronic Obstructi...
Location
GSK Investigational Site
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
PHASE4This is a randomised, double-blind, double-dummy, multinational, multicentr...
Location
205.389.1020 Boehringer Ingelheim Investigational Site